Anzeige
Mehr »
Donnerstag, 09.07.2026 - Börsentäglich über 12.000 News
Durchbruch in Nevada: Kupfer mit bloßem Auge sichtbar!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
30.06.Medical journal retracts Tavneos pivotal study article, complicating Amgen's defense effort
30.06.After monotherapy failure, AbbVie and Genmab tout Epkinly combo win in DLBCL
30.06.FDA selects Lilly, Regeneron, Fujifilm, 4 others for PreCheck Pilot Program
30.06.Unicycive turned away by FDA again over manufacturer's plant shortfalls
29.06.Zymeworks acquires struggling Theravance for $929M
29.06.FDA rejects Sobi's gout drug over manufacturing issues, sparing Amgen blockbuster
29.06.Look out, Amgen. Here comes Viridian with FDA nod for TED med Lumvoa
26.06.FDA slaps Dr. Reddy's Hyderabad biologics plant with seven observations in new Form 483
26.06.Sanofi under antitrust probe as European Commission kicks off formal proceedings
26.06.Pharma's Cannes-do attitude sees industry return to triumph
26.06.Europe's CHMP reverses endorsement of Amgen's Tavneos as FDA hearing looms
26.06.Eli Lilly taps AI to bring personal memories to life during its European radio show road trip
26.06.Fierce Pharma Asia-Historic solid tumor CAR-T nod; Inside Pfizer, Innovent's $10B pact; More China deals
26.06.Biogen launches 'Ready for More' HD Spinraza campaign with a focus on how we see SMA
26.06.BeOne boosts support for Blood Cancer United with $5M commitment
25.06.Bayer scores landmark victory as Supreme Court overturns Roundup verdict
25.06.FDA shines harsh light on Pinnacle after finding fault with photodynamic therapy videos
25.06.Merck KGaA throws down $11.3B for Bio-Techne in its biggest deal since 2015 Sigma-Aldrich buy
25.06.Novartis teams up with Becoming rentABLE for its new SMA campaign
25.06.Ionis scores transformational FDA label expansion for Tryngolza
25.06.Jubilant HollisterStier gets FDA warning letter for quality control problems
25.06.AstraZeneca spells out a community cancer screening strategy with the YMCA
24.06.Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO chief
24.06.Pfizer scores 1st expansion in 7 years for breast cancer blockbuster Ibrance
24.06. Stada, under new CapVest ownership, picks up horde of European consumer brands